PVALB and schizophrenia: We further characterized VPP1, calmodulin and parvalbumin by immunoblot in a cohort consisting of 7 schizophrenia subjects, 7 matched control subjects and 6 matched non-schizophrenia suicide subjects (Table 1, Cohort I).